NTLA
Price
$14.22
Change
-$0.00 (-0.00%)
Updated
Oct 31 closing price
111 days until earnings call
RXRX
Price
$6.32
Change
-$0.00 (-0.00%)
Updated
Oct 31 closing price
5 days until earnings call
Ad is loading...

NTLA vs RXRX

Header iconNTLA vs RXRX Comparison
Open Charts NTLA vs RXRXBanner chart's image
Intellia Therapeutics
Price$14.22
Change-$0.00 (-0.00%)
Volume$2.6M
CapitalizationN/A
Recursion Pharmaceuticals
Price$6.32
Change-$0.00 (-0.00%)
Volume$4.38M
CapitalizationN/A
View a ticker or compare two or three
NTLA vs RXRX Comparison Chart
Loading...
NTLA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
NTLA vs. RXRX commentary
Nov 02, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NTLA is a Buy and RXRX is a Buy.

COMPARISON
Comparison
Nov 02, 2024
Stock price -- (NTLA: $14.22 vs. RXRX: $6.33)
Brand notoriety: NTLA and RXRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NTLA: 129% vs. RXRX: 86%
Market capitalization -- NTLA: $2.13B vs. RXRX: $1.97B
NTLA [@Biotechnology] is valued at $2.13B. RXRX’s [@Biotechnology] market capitalization is $1.97B. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NTLA’s FA Score shows that 0 FA rating(s) are green whileRXRX’s FA Score has 0 green FA rating(s).

  • NTLA’s FA Score: 0 green, 5 red.
  • RXRX’s FA Score: 0 green, 5 red.
According to our system of comparison, RXRX is a better buy in the long-term than NTLA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NTLA’s TA Score shows that 4 TA indicator(s) are bullish while RXRX’s TA Score has 3 bullish TA indicator(s).

  • NTLA’s TA Score: 4 bullish, 5 bearish.
  • RXRX’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, NTLA is a better buy in the short-term than RXRX.

Price Growth

NTLA (@Biotechnology) experienced а -10.28% price change this week, while RXRX (@Biotechnology) price change was -0.47% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

Reported Earning Dates

NTLA is expected to report earnings on Feb 20, 2025.

RXRX is expected to report earnings on Mar 04, 2025.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RXRX($1.87B) has a higher market cap than NTLA($1.5B). RXRX YTD gains are higher at: -35.801 vs. NTLA (-53.362). RXRX has higher annual earnings (EBITDA): -348.35M vs. NTLA (-514.18M). NTLA has more cash in the bank: 691M vs. RXRX (474M). RXRX has less debt than NTLA: RXRX (89.9M) vs NTLA (106M). RXRX has higher revenues than NTLA: RXRX (48.6M) vs NTLA (46M).
NTLARXRXNTLA / RXRX
Capitalization1.5B1.87B81%
EBITDA-514.18M-348.35M148%
Gain YTD-53.362-35.801149%
P/E RatioN/AN/A-
Revenue46M48.6M95%
Total Cash691M474M146%
Total Debt106M89.9M118%
FUNDAMENTALS RATINGS
NTLA: Fundamental Ratings
NTLA
OUTLOOK RATING
1..100
5
VALUATION
overvalued / fair valued / undervalued
1..100
41
Fair valued
PROFIT vs RISK RATING
1..100
95
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
93
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NTLARXRX
RSI
ODDS (%)
Bullish Trend 2 days ago
84%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 5 days ago
79%
Bullish Trend 5 days ago
83%
Declines
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
81%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
NTLA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL225.91-4.19
-1.82%
Apple
SPY568.64-11.37
-1.96%
SPDR® S&P 500® ETF Trust
BTC.X70215.190000-2124.351600
-2.94%
Bitcoin cryptocurrency
TSLA249.85-7.70
-2.99%
Tesla
GME22.18-1.10
-4.73%
GameStop Corp

NTLA and

Correlation & Price change

A.I.dvisor indicates that over the last year, NTLA has been closely correlated with BEAM. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if NTLA jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NTLA
1D Price
Change %
NTLA100%
-0.77%
BEAM - NTLA
69%
Closely correlated
-2.58%
VCYT - NTLA
69%
Closely correlated
-3.60%
EDIT - NTLA
68%
Closely correlated
-3.97%
CRSP - NTLA
63%
Loosely correlated
-3.23%
PRME - NTLA
60%
Loosely correlated
-4.55%
More

RXRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RXRX has been loosely correlated with BEAM. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if RXRX jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RXRX
1D Price
Change %
RXRX100%
-5.24%
BEAM - RXRX
63%
Loosely correlated
-2.58%
CRSP - RXRX
57%
Loosely correlated
-3.23%
PRME - RXRX
55%
Loosely correlated
-4.55%
EXAI - RXRX
55%
Loosely correlated
-4.97%
NTLA - RXRX
53%
Loosely correlated
-0.77%
More